Shanna Johnson
Acute Care · Sun City, AZNPI 1942954367
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,315 of the $9,315 with a category attached, or 78.5%. 38 manufacturers reported payments, led by Medtronic at 33.2% of the total. 2025 is the largest year on record at $3,951, 7.0 times the $562 reported in 2022. Among acute care clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 393 payments — averaging $23.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Novartis$704
- UCB, Inc.$603
- Pfizer$593
- Abbott$576
- AbbVie$546
- plus $3K from 32 others
What the payments were for
- Speaking & faculty fees$601%
- Travel & lodging$1,83720%
- Food & beverage$7,31579%
- Education$1031%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 38 | $3,094 |
| Novartis | 42 | $704 |
| UCB, Inc. | 54 | $603 |
| Pfizer | 29 | $593 |
| Abbott | 6 | $576 |
| AbbVie | 39 | $546 |
| Biogen | 41 | $419 |
| Amneal Pharmaceuticals LLC | 24 | $273 |
| Argenx US, Inc. | 14 | $254 |
| Otsuka America Pharmaceutical, Inc. | 4 | $248 |
| SK Life Science, Inc. | 11 | $214 |
| AstraZeneca | 8 | $201 |
| Lilly USA, LLC | 9 | $195 |
| Teva Pharmaceuticals USA, Inc. | 7 | $182 |
| Acadia Pharmaceuticals Inc | 10 | $155 |
| Eisai Inc. | 6 | $112 |
| Harmony Biosciences LLC | 5 | $110 |
| Corium, LLC | 10 | $89 |
| Sumitomo Pharma America, Inc. | 5 | $82 |
| Amgen | 4 | $73 |
| MDD US Operations, LLC | 1 | $60 |
| Neurocrine Biosciences, Inc. | 2 | $59 |
| Grifols USA, LLC | 2 | $55 |
| C2n Diagnostics, LLC | 2 | $53 |
| Alnylam Pharmaceuticals Inc. | 3 | $48 |
| Octapharma USA, Inc. | 1 | $45 |
| Neurelis, Inc. | 2 | $38 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $34 |
| Avion Pharmaceuticals | 2 | $33 |
| Banner Life Sciences, LLC | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 1 | $29 |
| Painteq LLC | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Tanabe Pharma America, Inc. | 1 | $13 |
| Bristol Myers Squibb | 1 | $13 |
| Dynasplint Systems Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PERCEPT PC BRAINSENSE$1,710
- INFINITY$411
- SenSight$243
- REXULTI$119
- INTELLIS ADAPTIVESTIM$106
How this compares
$9,315 in reported general payments places this provider in the 95th percentile of 482 acute care providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 30 | $53,765 |
| AptiomEslicarbazepine Acetate | 12 | $28,694 |
| Memantine Hcl | 1,102 | $28,425 |
| BriviactBrivaracetam | 11 | $20,893 |
| RytaryCarbidopa/Levodopa | 19 | $20,838 |
| Ajovy SyringeFremanezumab-Vfrm | 15 | $15,769 |
| Duloxetine Hcl | 327 | $9,652 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $8,495 |
| Gabapentin | 261 | $5,570 |
| Divalproex Sodium | 210 | $4,756 |
| Topiramate | 392 | $4,401 |
| Levetiracetam | 121 | $3,317 |
| Primidone | 47 | $2,678 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 78 | $2,582 |
| Ropinirole Hcl | 150 | $2,399 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $593 | $53,76530 claims |
| UCB, Inc.Briviact | $603 | $20,89311 claims |
| Amneal Pharmaceuticals LLCRytary | $273 | $20,83819 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 482 acute care providers in Arizona.
Other acute care in Sun City
- Brittany PelleranSun City$10K
- Nicole CiffoneTucson$162K
- Kim KrmpoticPhoenix$79K
- Stephanie WilsonScottsdale$37K
- Laura Cook-GongoraPhoenix$32K
- Cathy PaynePhoenix$26K
- Chandra SorrellePhoenix$16K
- Nicole RauscherPhoenix$12K
- Seania BristolMesa$11K
- Brooke GambinoPhoenix$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.